7 research outputs found
Predictors and outcome of surgical repair of obstetric fistula at a regional referral hospital, Mbarara, western Uganda
<p>Abstract</p> <p>Background</p> <p>Obstetric fistula although virtually eliminated in high income countries, still remains a prevalent and debilitating condition in many parts of the developing world. It occurs in areas where access to care at childbirth is limited, or of poor quality and where few hospitals offer the necessary corrective surgery.</p> <p>Methods</p> <p>This was a prospective observational study where all women who attended Mbarara Regional Referral Hospital in western Uganda with obstetric fistula during the study period were assessed pre-operatively for social demographics, fistula characteristics, classification and outcomes after surgery. Assessment for fistula closure and stress incontinence after surgery was done using a dye test before discharge</p> <p>Results</p> <p>Of the 77 women who were recruited in this study, 60 (77.9%) had successful closure of their fistulae. Unsuccessful fistula closure was significantly associated with large fistula size (Odds Ratio 6 95% Confidential interval 1.46-24.63), circumferential fistulae (Odds ratio 9.33 95% Confidential interval 2.23-39.12) and moderate to severe vaginal scarring (Odds ratio 12.24 95% Confidential interval 1.52-98.30). Vaginal scarring was the only factor independently associated with unsuccessful fistula repair (Odds ratio 10 95% confidential interval 1.12-100.57). Residual stress incontinence after successful fistula closure was associated with type IIb fistulae (Odds ratio 5.56 95% Confidential interval 1.34-23.02), circumferential fistulae (Odds ratio 10.5 95% Confidential interval 1.39-79.13) and previous unsuccessful fistula repair (Odds ratio 4.8 95% Confidential interval 1.27-18.11). Independent predictors for residual stress incontinence after successful fistula closure were urethral involvement (Odds Ratio 4.024 95% Confidential interval 2.77-5.83) and previous unsuccessful fistula repair (Odds ratio 38.69 95% Confidential interval 2.13-703.88).</p> <p>Conclusions</p> <p>This study demonstrated that large fistula size, circumferential fistulae and marked vaginal scarring are predictors for unsuccessful fistula repair while predictors for residual stress incontinence after successful fistula closure were urethral involvement, circumferential fistulae and previous unsuccessful fistula repair.</p
Analysis of the CD1 Antigen Presenting System in Humanized SCID Mice
CD1 molecules are glycoproteins that present lipids and glycolipids for recognition by T cells. CD1-dependent immune activation has been implicated in a wide range of immune responses, however, our understanding of the role of this pathway in human disease remains limited because of species differences between humans and other mammals: whereas humans express five different CD1 gene products (CD1a, CD1b, CD1c, CD1d, and CD1e), muroid rodents express only one CD1 isoform (CD1d). Here we report that immune deficient mice engrafted with human fetal thymus, liver, and CD34+ hematopoietic stem cells develop a functional human CD1 compartment. CD1a, b, c, and d isoforms were highly expressed by human thymocytes, and CD1a+ cells with a dendritic morphology were present in the thymic medulla. CD1+ cells were also detected in spleen, liver, and lungs. APCs from spleen and liver were capable of presenting bacterial glycolipids to human CD1-restricted T cells. ELISpot analyses of splenocytes demonstrated the presence of CD1-reactive IFN-γ producing cells. CD1d tetramer staining directly identified human iNKT cells in spleen and liver samples from engrafted mice, and injection of the glycolipid antigen α-GalCer resulted in rapid elevation of human IFN-γ and IL-4 levels in the blood indicating that the human iNKT cells are biologically active in vivo. Together, these results demonstrate that the human CD1 system is present and functionally competent in this humanized mouse model. Thus, this system provides a new opportunity to study the role of CD1-related immune activation in infections to human-specific pathogens
Polyelectrolyte Multilayers Promote Stent-Mediated Delivery of DNA to Vascular Tissue
We
report an approach to deliver DNA to vascular tissue <i>in vivo</i> using intravascular stents coated with degradable,
DNA-containing polyelectrolyte multilayers (PEMs). Ionically cross-linked
multilayers ∼120 nm thick were fabricated layer-by-layer on
the surfaces of balloon-mounted stainless steel stents using plasmid
DNA and a hydrolytically degradable poly(β-amino ester) (polymer <b>1</b>). Characterization of stents coated using a fluorescently
end-labeled analog of polymer <b>1</b> revealed film erosion
to be uniform across the surfaces of the stents; differential stresses
experienced upon balloon expansion did not lead to faster film erosion
or dose dumping of DNA in areas near stent joints when stents were
incubated in physiologically relevant media. The ability of film-coated
stents to transfer DNA and transfect arterial tissue <i>in vivo</i> was then investigated in pigs and rabbits. Stents coated with films
fabricated using fluorescently labeled DNA resulted in uniform transfer
of DNA to sub-endothelial tissue in the arteries of pigs in patterns
corresponding to the locations and geometries of stent struts. Stents
coated with films fabricated using polymer <b>1</b> and plasmid
DNA encoding EGFP resulted in expression of EGFP in the medial layers
of stented tissue in both pigs and rabbits two days after implantation.
The results of this study, combined with the modular and versatile
nature of layer-by-layer assembly, provide a polymer-based platform
that is well suited for fundamental studies of stent-mediated gene
transfer. With further development, this approach could also prove
useful for the design of nonviral, gene-based approaches for prevention
of complications that arise from the implantation of stents and other
implantable interventional devices